SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001457612-21-000092
Filing Date
2021-07-29
Accepted
2021-07-29 16:38:29
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gnca-20210630.htm   iXBRL 10-Q 1076940
2 EX-31.1 a2021q2ex311.htm EX-31.1 11823
3 EX-31.2 a2021q2ex312.htm EX-31.2 11465
4 EX-32 a2021q2ex32.htm EX-32 9269
10 gnca-20210630_g1.jpg GRAPHIC 16581
  Complete submission text file 0001457612-21-000092.txt   5469672

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20210630.xsd EX-101.SCH 35609
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gnca-20210630_cal.xml EX-101.CAL 45850
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnca-20210630_def.xml EX-101.DEF 190940
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20210630_lab.xml EX-101.LAB 498244
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20210630_pre.xml EX-101.PRE 332740
11 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20210630_htm.xml XML 890134
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36289 | Film No.: 211128009
SIC: 2836 Biological Products, (No Diagnostic Substances)